BioMerieux (BioMerieux) Accumulated Depreciation : $-1,575 Mil (As of Dec. 2023)

View and export this data going back to 2009. Start your Free Trial

What is BioMerieux Accumulated Depreciation?

Note: A negative number here means the assets are depreciated. When depricates more, the absolute value gets bigger.

BioMerieux's quarterly accumulated depreciation increased from Dec. 2022 ($-1,413 Mil) to Jun. 2023 ($-1,507 Mil) and increased from Jun. 2023 ($-1,507 Mil) to Dec. 2023 ($-1,575 Mil).

BioMerieux's annual accumulated depreciation increased from Dec. 2021 ($-1,381 Mil) to Dec. 2022 ($-1,413 Mil) and increased from Dec. 2022 ($-1,413 Mil) to Dec. 2023 ($-1,575 Mil).

BioMerieux Accumulated Depreciation Historical Data

The historical data trend for BioMerieux's Accumulated Depreciation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioMerieux Accumulated Depreciation Chart

BioMerieux Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accumulated Depreciation

Get a 7-Day Free Trial

-1,195.22

-1,343.80

-1,381.47

-1,413.24

-1,574.92

BioMerieux Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Accumulated Depreciation	Get a 7-Day Free Trial															-1,381.47	-1,380.76	-1,413.24	-1,506.50	-1,574.92

BioMerieux Accumulated Depreciation Calculation

The cumulative depreciation of an asset up to a single point in its life. Regardless of the method used to calculate it, the depreciation of an asset during a single period is added to the previous period's accumulated depreciation to get the current accumulated depreciation.

BioMerieux Accumulated Depreciation Related Terms

Thank you for viewing the detailed overview of BioMerieux's Accumulated Depreciation provided by GuruFocus.com. Please click on the following links to see related term pages.

BioMerieux (BioMerieux) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » BioMerieux SA (OTCPK:BMXMF) » Definitions » Accumulated Depreciation

Comparable Companies

Traded in Other Exchanges

BIMp:UK 0RUG:UK BIM:France EYWN:Germany BIM:Austria

Address

Marcy l’Etoile, Lyon, FRA, 69280

Website

http://www.biomerieux.com

BioMerieux designs, develops, and manufactures a broad portfolio of in vitro diagnostics for detecting disease-causing pathogens and contamination. The company operates in four segments: molecular biology (38% of 2021 sales), microbiology (31%), immunoassays (14%), and industrial applications (about 17%). The Americas account for the largest portion of the firm's revenue (49%), followed by Europe, the Middle East, and Africa (33%), and Asia-Pacific (18%). BioMerieux is headquartered in Marcy-l'Etoile, France.

BioMerieux (BioMerieux) Headlines

From GuruFocus

French multidisciplinary consortium ARPEGE awarded public funding of close to �9 million to fight antibiotic resistance

By PRNewswire PRNewswire • 01-06-2022

bioM�rieux Introduces GENE-UP� ENVIROPRO�

By PRNewswire PRNewswire • 02-02-2023